Académique Documents
Professionnel Documents
Culture Documents
Mirjami Siltanen, MD, PhD,a,b Karoliina Wehkalampi, MD, PhD,a,c Petteri Hovi, MD,a,c Johan G. Eriksson, MD, PhD,a,d,e,f,g
rvenpa
a
, MD, PhD,c Sture Andersson, MD, PhD,c and
Sonja Strang-Karlsson, MD,a,c Anna-Liisa Ja
Eero Kajantie, MD, PhDa,c Helsinki, Hyvinkaa, and Vasa, Finland
Background: Immunologic pathways are primed in early life.
Preterm birth can influence this process and thereby affect
whether a person will have atopy later in life. Previous studies
on the effects of preterm birth on atopy in adulthood have been
inconclusive and limited to children or subjects born
moderately preterm.
Objective: Our aim was to compare the incidence of atopy
among young adults who were born preterm and at very low
_1500 g) with that of term-born young adults
birth weight (<
(control subjects).
Methods: The study comprised 166 adults who were born preterm
and at very low birth weight and 172 control subjects, all of whom
were from the Helsinki Study of Very Low Birth Weight Adults.
We assessed atopic predisposition at ages 18 to 27 years using skin
prick tests for 6 common aeroallergens and measurements of
serum concentrations of total IgE and 3 types of allergen-specific
(cat, birch, and timothy) IgE. We asked the subjects whether they
had been given a diagnosis of asthma or allergic rhinitis or had
atopic eczema and analyzed data by using logistic or linear
regression, adjusting for potential confounding factors.
Results: The risk for having at least 1 positive reaction on a skin
prick test was reduced (adjusted odds ratio, 0.43; 95% CI,
From athe Division of Welfare and Health Promotion, Department of Chronic Disease
Prevention, Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki; bHyvinkaa Hospital, Hyvinkaa; cthe Hospital for Children and Adolescents and
f
the Unit of General Practice, Helsinki University Central Hospital, Helsinki; dthe Department of General Practice and Primary Health Care, University of Helsinki; eVasa
Central Hospital, Vasa; and gFolkhalsan Research Centre, Helsinki.
The Helsinki Study of Very Low Birth Weight Adults has received grant support from the
following sources: the Finnish Foundation for Pediatric Research (E.K., K.W., M.S.,
P.H., and S.A.), Finska Lakaresallskapet (J.G.E. and S.A.), the Finnish Special Governmental Subsidy for Health Sciences (J.G.E. and S.A.), the Academy of Finland
(K.W., J.G.E., S.A., and E.K.), the Biomedicum Helsinki Foundation (S.S.K.), the
Emil Aaltonen Foundation, the Finnish Concordia Foundation (S.S.K.), the Finnish
Medical Society Duodecim (E.K.), the Finnish National Graduate School of Clinical
Investigation (S.S.K.), the Jalmari and Rauha Ahokas Foundation (E.K.), the Juho
Vainio Foundation (J.G.E. and E.K.), the Novo Nordisk Foundation (J.G.E. and
E.K.), the Paivikki and Sakari Sohlberg Foundation (J.G.E. and E.K.), the Pediatric
Graduate School (P.H. and S.S.K.), the Clinical Graduate School in Paediatrics and
Obstetrics/Gynaecology (P.H.), the University of Helsinki (J.G.E.), the Perklen Foundation (S.S.K.), the Research Foundation for the Orion Corporation (P.H.), the Signe
and Ane Gyllenberg Foundation (J.G.E. and E.K.), the Sigrid Juselius Foundation
(S.A. and E.K.), the Waldemar von Frenckell Foundation (S.S.K.), Vasa Nation
(S.S.K.), Wiipurilainen Osakunta (E.K.) at Helsinki University, the Wilhelm and
Else Stockmann Foundation (S.S.K.), and the Yrjo Jahnsson Foundation (P.H.,
J.G.E., and E.K.).
Disclosure of potential conflict of interest: M. Siltanen has received research support
from the Finnish Foundation of Pediatric Research. The rest of the authors have declared that they have no conflict of interest.
Received for publication April 18, 2010; revised December 12, 2010; accepted for publication December 16, 2010.
Available online February 18, 2011.
Reprint requests: Eero Kajantie, MD, PhD, National Institute for Health and Welfare,
Mannerheimintie 164, PO Box 30, FIN-00271 Helsinki, Finland. E-mail: eero.
kajantie@helsinki.fi.
0091-6749/$36.00
2011 American Academy of Allergy, Asthma & Immunology
doi:10.1016/j.jaci.2010.12.1107
METHODS
Study participants
The original study cohort consisted of 474 consecutive subjects who were
born at very low birth weight between 1978 and 1985 at one of several maternity
935
936 SILTANEN ET AL
Abbreviation used
OR: Odds ratio
hospitals that serve the province of Uusimaa, Finland. Of these, 335 (70.7%)
were discharged alive from the neonatal intensive care unit of Childrens Hospital at the Helsinki University Central Hospital, the only tertiary neonatal care
center of this area. We selected a comparison group of term-born (gestational
_37 weeks) subjects who were not born small for their gestational age
age >
(birth weight no more than 2 SDs below the mean)28 and matched for sex,
age, and birth hospital (clustered matching; control subjects). We invited
255 subjects of very low birth weight and 314 control subjects who were living
in the greater Helsinki area to participate in the Helsinki Study of Very Low
Birth Weight Adults. One hundred sixty-six (65.1%) subjects of very low birth
weight and 172 (54.8%) control subjects attended. Baseline characteristics of
the nonparticipating very-low-birth-weight subjects were similar to those of
the subjects who participated in the study, except that cerebral palsy at age
15 months was more common among nonparticipants. The nonparticipating
and participating control subjects did not differ in any characteristics.29
Race or ethnicity are not recorded in Finnish hospital records, but at the
time the study subjects were born, almost all inhabitants of Finland were of
Finnish ancestry.
Data collection
The Helsinki Study of Very Low Birth Weight Adults was designed to study
in detail the adult health of subjects born preterm at very low birth weight,
including analysis of allergies. The participants completed a structured
questionnaire that covered their own and their parents medical, psychosocial,
educational, and environmental histories. The subjects also attended a clinical
examination, which included height and weight measurements.
History of atopic diseases. Data on atopic diseases, such as
asthma, allergic rhinitis, and atopic eczema, were obtained from the questionnaire. Although the questionnaire has not, to our knowledge, been
validated against medical records, it has been used in previous population
studies.30 Asthma and allergic rhinitis were recorded if the participant reported that these were diagnosed by a doctor. Atopic eczema was recorded
if the participant had a history of infant eczema (milk crust) or atopic dermatitis. Perinatal and neonatal data were obtained from hospital records.
Skin prick testing. During the clinical examination, skin prick tests
were performed by 1 trained research nurse on the volar surface of the forearm,
according to a standard technique. We used 6 common aeroallergen Soluprick
solutions from ALK-Abell
o (Copenhagen, Denmark): birch, timothy, mugwort, cat, dog, and Dermatophagoides pteronyssinus; histamine hydrochloride (10 mg/mL) was used as the positive control, and 50% glycerol
(Soluprick) was used as the negative control. Test results were considered to
be positive if the mean diameter of the wheal (calculated by using the largest
diameter of the wheal and the diameter perpendicular to that) was 3 mm or
greater and the negative control solution caused no reaction.31
IgE measurements. Blood samples were collected during the clinic
visit. From frozen serum samples, we determined total concentrations of IgE
and concentrations of 3 types of allergen-specific IgE (timothy, birch, and cat).
Measurements of total IgE levels were performed with a clinical chemistry
analyzer (Architect c8000l Abbott Laboratories, Abbott Park, Ill) with an
immunoturbidimetric method (Biokit, Barcelona, Spain) at the Disease Risk
Unit of the National Institute for Health and Welfare in Helsinki, Finland. The
detection limit of this assay is 13 IU/mL; values of less than this were entered
in our database as 12 IU/mL. Allergen-specific IgE levels were measured by
using an immunofluoroenzyme method on an ImmunoCAP Specific IgE FEIA
analyzer (ImmunoCAP 1000; Phadia AB, Uppsala, Sweden) at the Helsinki
University Central Hospital Allergy Laboratory. The allergen-specific IgE
concentrations were reported as values ranging from 0 to 100 kU/L or greater
than 100 kU/L; values of greater than this were entered as 101 kU/L.
Outcome measures
Skin prick test results and IgE concentrations. The
primary outcome was atopy, which was defined as presence of at least 1 positive
skin prick test reaction. Additional indicators of atopy included serum concentrations of total IgE or allergen-specific IgE (timothy, birch and cat), which were
used as continuous variables; each allergen-specific IgE concentration was
also dichotomized, with a high value defined as greater than 0.8 kU/L.16
History of atopic diseases. The secondary outcomes included a
self-reported history of any of the following atopic diseases: asthma (doctor
diagnosed), allergic rhinitis (doctor diagnosed), and atopic eczema.
Other comparisons among the very-low-birthweight group. To investigate other differences in perinatal characteristics of the very-low-birth-weight group, we examined the effects of length of
gestation and early-life events, such as the effect of infections on skin prick test
results.
Statistical analyses
To compare background characteristics between groups, we used the x2 test
for dichotomous variables and the Student t test for continuous variables.
To compare dichotomous outcome measures (positive skin prick test
reactions, high concentrations of allergen-specific IgE, and history of atopy)
between groups, we used logistic regression for a crude assessment and
multivariate logistic regression to include covariates in the model. The
potential covariates used in this adjustment included maternal and paternal
_1 of the atopic diseases (asthma, allergic rhinitis,
atopy, defined as a history of >
or atopic eczema [yes/no]). Parental education was categorized into 4 levels:
elementary school, high school, intermediate, and university (dummy coded).
Analyses also include the number of older siblings (dummy coded),
maternal smoking during pregnancy (yes/no), birth by means of cesarean
section (yes/no), sex, current age, body mass index, current weekly smoking of
the participant (yes/no), and cats or dogs at home during the first year of life
(yes/no) or currently (yes/no); these factors can affect predisposition to atopy
or very low birth weight.32,33
Serum concentrations of total and allergen-specific IgE were log transformed to attain normality and entered as dependent variables in linear
regression adjusted for the same covariates as in logistic regression (see above).
The results were reported in odds ratios (ORs) or percentage differences
with 95% CIs and P values. P values of less than .050 were considered statistically significant. Significance tests were 2-sided.
Ethics
The study protocol was approved by the Ethics Committee of Children and
Adolescents Diseases and Psychiatry at Helsinki and Uusimaa Hospital District. Each participant signed an informed consent form.
RESULTS
Characteristics of study participants
Table I shows the characteristics of the study participants. The
mean birth weight of the very-low-birth-weight group was 1120 g
(range, 600-1500 g), and that of the control subjects was 3593 g
(range, 2560-4930 g); the mean gestational ages were 29.2 weeks
(range, 24.0-35.6) and 40.1 weeks (range, 37.0-42.9), respectively. The control subjects smoked more often than subjects
from the very-low-birth-weight group, whereas the very-lowbirth-weight participants were more likely to have a pet at
home. Parental atopy did not differ between the groups, but the
educational level of parents was higher among control subjects.
The mean gestational age of the very-low-birth-weight subgroup
who were born small for gestational age was, by definition, greater
than of the subgroup who were of the appropriate size for
gestational age (31.2 weeks [range, 27.0-35.6 weeks] vs 28.2 weeks
[range, 24.0-31.7 weeks], P <.001). There were also other expected
differences in obstetric backgrounds of the mothers; preeclampsia
complicated the pregnancy (41.8% vs 10.8%, P < .001), and delivery was performed by means of cesarean section (85.5% vs 50.5%,
P < .001) more often among infants born small for gestational
age than those who were appropriate size for gestational age.
Skin prick test reactions and IgE concentrations
Subjects of very low birth weight were less likely to have
positive skin prick test reactions than control subjects: 45.5% had
at least 1 positive reaction to one of the 6 common aeroallergens
compared with 57.9% of the control subjects (crude OR, 0.61;
95% CI, 0.39-0.93; P 5.023; Table II). Adjustment for covariates
reduced the OR for allergic reactions among the very-low-birthweight group (adjusted OR, 0.48; 95% CI, 0.27-0.86; P 5 .013).
We also compared positive skin prick test reactions between the
subgroup of subjects of extremely low birth weight (birth weight
<
_1000 g) and control subjects, which further reduced the OR for
reactivity (adjusted OR, 0.24; 95% CI, 0.10-0.58; P 5 .002).
Of the covariates, male sex (OR, 2.03; 95% CI, 1.26-3.29; P 5
.004) and maternal atopy (OR, 1.98; 95% CI, 1.16-3.35; P 5 .012)
were independently associated with an increased risk of having at
least 1 positive skin prick test reaction. Older age of the participant
was associated with positive reactions to dog (OR, 1.16; 95% CI,
1.02-1.31; P 5 .020) and timothy (OR, 1.14; 95% CI, 1.01-1.28;
P 5 .040) allergens. Maternal smoking during pregnancy was
associated with positive reactions to mugwort (OR, 2.80; 95%
CI, 1.11-7.08; P 5.030), and delivery by means of cesarean section
was associated with positive reactions to birch (OR, 2.59; 95% CI,
1.34-5.02; P 5 .005).
Very-low-birth-weight subjects were less likely than control
subjects to have high serum concentrations of any of the types of
allergen-specific IgE measured (adjusted OR, 0.48; 95% CI,
0.250.91), especially cat-specific IgE (Table II). When the
concentrations were analyzed as continuous variables, the mean
concentration of IgE for cat allergen was significantly less in
the very-low-birth-weight group than in the control group (25%
less than control subjects; 95% CI, 43% to 2.3% less; P 5 .033;
Table III). The mean concentration of total IgE did not differ significantly between the very-low-birth-weight group and the control subjects when adjusted for all covariates.
Subgroup comparison of small versus appropriate
size for gestational age. The numbers of subjects having at
least 1 positive reaction on a skin prick test were similar between
SILTANEN ET AL 937
938 SILTANEN ET AL
VLBW (n 5 166)
71 (42.8)
1120
29.2
103
27
35
28
14
19
12
30
14
29.8
31
36
P value*
Missing value,
VLBW/term
69 (40.1)
.620
0/0
3593 (471)
40.1 (1.1)
20 (11.6)
0
13 (7.6)
<.001
<.001
<.001
0
0
29.7 (4.7)
28 (16.3)
32 (18.6)
.911
.562
.428
0/0
0/0
0/0
0/0
0/0
3
3
3
3
6
5/1
0/0
0/0
3/0
22.4 (2.1)
22.5 (2.2)
.895
0/0
162.0 (7.7)
174.6 (7.7)
167.3 (6.8)
180.6 (6.4)
<.001
<.001
0/0
0/0
.382
.021
.013
.037
0/0
0/0
4/0
0/0
22.3
22.0
45
62
(221)
(2.2)
(62.0)
(16.3)
(21.1)
(16.9)
(8.4)
(11.4)
(7.2)
(21.7)
(8.4)
(4.7)
(18.7)
(22.1)
Term (n 5 172)
(4.0)
(3.6)
(27.8)
(37.3)
22.8
23.3
70
46
(3.7)
(3.2)
(40.7)
(26.7)
<.001
17 (10.5)
9 (5.7)
14 (8.1)
9 (5.3)
.459
.873
4/0
8/2
13 (8.6)
7 (4.7)
12 (7.6)
7 (4.5)
.757
.950
14/14
17/18
29 (18.4)
18 (11.8)
36 (21.8)
23 (14.5)
.438
.494
.024
8/7
14/13
3/1
17
42
59
45
11
31
56
73
.116
.341
3/0
3/0
(10.4)
(25.8)
(36.2)
(27.6)
1.5 (0-6)
0.7 (0-4)
(6.4)
(18.1)
(32.7)
(42.7)
1.8 (0-13)
0.8 (0-6)
_1500 g).
VLBW, Very low birth weight (<
*The t test was used for continuous variables, and the x2 test was used for categorical variables.
Data available or relevant for the VLBW group only.
SILTANEN ET AL 939
TABLE II. Numbers and differences (crude and adjusted ORs and 95% CIs) in the numbers of subjects having positive skin prick test
reactions, high serum allergen-specific IgE concentrations, or atopic diseases between those born preterm at VLBW and control
subjects born at term
VLBW
(n 5 166)
Atopic manifestation
Term
(n 5 172)
Crude
OR (95% CI)
Adjusted
OR (95% CI)y
Missing value,
VLBW/term
75
45
43
22
33
38
14
(45.5%)
(27.3%)
(26.1%)
(13.3%)
(20.0%)
(23.0%)
(8.5%)
99
53
58
44
52
53
15
(57.9%)
(31.0%)
(33.8%)
(25.7%)
(30.6%)
(31.0%)
(8.8%)
0.61
0.84
0.69
0.44
0.57
0.67
0.96
(0.39-0.93)*
(0.52-1.34)
(0.43-1.09)
(0.25-0.78)*
(0.34-0.94)*
(0.41-1.08)
(0.45-2.05)
0.48
0.58
0.71
0.41
0.48
0.55
1.43
(0.27-0.86)*
(0.30-1.11)
(0.38-1.33)
(0.20-0.86)*
(0.24-0.95)*
(0.28-1.07)
(0.53-3.90)
1/1
1/1
1/1
1/1
1/2
1/1
1/2
51
30
34
25
(30.4%)
(18.1%)
(20.2%)
(14.9%)
65
44
44
39
(37.8%)
(25.6%)
(25.6%)
(22.7%)
0.73
0.75
0.64
0.60
(0.46-1.15)
(0.45-1.25)
(0.38-1.08)
(0.35-1.05)
0.48
0.60
0.67
0.41
(0.25-0.91)*
(0.29-1.24)
(0.33-1.37)
(0.19-0.91)*
0/0
0/0
0/0
0/0
29 (17.9%)
49 (30.1%)
31 (19.7%)
21 (12.2%)
42 (24.4%)
40 (23.7%)
1.57 (0.85-2.88)
1.33 (0.82-2.16)
0.79 (0.47-1.35)
1.71 (0.80-3.68)
1.34 (0.71-2.50)
0.61 (0.30-1.24)
4/0
3/0
9/3
_1500 g).
VLBW, Very low birth weight (<
*Boldfaced text denotes P < .05.
Covariates used in the adjustment: maternal and paternal atopy, parental education, number of elder siblings, maternal smoking during pregnancy, cesarean section, sex, current
age and body mass index, smoking, cats or dogs at home during the first year, or currently.
TABLE III. Mean differences in percentages and 95% CIs in levels of serum total IgE and 3 types of allergen-specific IgE between VLBW
and term-born control subjects and between subjects at VLBW born SGA and AGA obtained by means of linear regression adjusted for
covariates*
Atopic manifestation
VLBW (n 5 166) vs
term (n 5 172)
P value
P value
.499
.016
.078
.361
.033
.267
.040
.096
Values are shown as mean differences (percentages) and 95% CIs. Boldfaced text denotes P < .05.
_1500 g).
AGA, Appropriate for gestational age; SGA, small for gestational age; VLBW, very low birth weight (<
*Covariates used in the adjustment: maternal and paternal atopy, parental education, number of older siblings, maternal smoking during pregnancy, cesarean section, sex, current
age and body mass index, smoking, cats or dogs at home during the first year, or currently.
940 SILTANEN ET AL
TABLE IV. Numbers and differences (crude and adjusted ORs and 95% CIs) in the numbers of subjects with positive skin prick test
reactions, high serum allergen-specific IgE concentrations, or atopic diseases between VLBW subjects born SGA compared with VLBW
subjects born AGA
Atopic manifestation
VLBW SGA
(n 5 55)
VLBW AGA
(n 5 111)
30
19
17
8
13
18
8
(55.6%)
(35.2%)
(31.5%)
(14.8%)
(24.1%)
(33.3%)
(14.8%)
45
26
26
14
20
20
6
(40.5%)
(23.4%)
(23.4%)
(12.6%)
(18.0%)
(18.0%)
(5.4%)
1.83
1.78
1.50
1.20
1.44
2.28
3.04
(0.95-3.54)
(0.87-3.61)
(0.73-3.09)
(0.47-3.07)
(0.66-3.18)
(1.08-4.79)*
(1.00-9.27)*
1.68
1.26
1.19
0.95
1.47
1.89
4.37
(0.75-3.72)
(0.54-2.97)
(0.42-2.88)
(0.30-3.04)
(0.55-3.93)
(0.75-4.74)
(1.02-18.69)*
1/0
1/0
1/0
1/0
1/0
1/0
1/0
24
18
14
11
(43.7%)
(32.7%)
(25.5%)
(20.0%)
27
16
16
14
(24.3%)
(14.4%)
(14.4%)
(12.7%)
2.41
2.89
2.03
1.73
(1.21-4.79)*
(1.33-6.26)*
(0.91-4.54)
(0.73-4.12)
2.57
2.81
2.87
2.01
(1.10-5.99)*
(1.09-7.22)*
(1.04-7.94)*
(0.69-5.89)
0/0
0/0
0/0
0/0
9 (17.3%)
17 (32.1%)
11 (22.4%)
20 (18.2%)
32 (29.1%)
29 (18.5%)
0.94 (0.40-2.24)
1.15 (0.57-2.34)
1.27 (0.56-2.92)
Adjusted OR
(95% CI)y
0.71 (0.25-1.98)
0.70 (0.28-1.73)
1.04 (0.37-2.86)
Missing value,
SGA/AGA
3/1
2/1
6/3
_1500 g).
AGA, Appropriate for gestational age; SGA, small for gestational age; VLBW, very low birth weight (<
_ .05.
*Boldfaced text denotes P <
Covariates used in the adjustment: maternal and paternal atopy, parental education, number of older siblings, maternal smoking during pregnancy, cesarean section, sex, current
age and body mass index, smoking, cats or dogs at home during the first year, or currently.
The lower incidence of atopy among subjects born preterm and at very low birth weight supports the hypothesis
that propensity for atopy is determined during early
stages of development.
REFERENCES
1. Gillman MW. Developmental origins of health and disease. N Engl J Med 2005;
353:1848-50.
SILTANEN ET AL 941
2. Gluckman PD, Hanson MA, Buklijas T. A conceptual framework for the developmental origins of health and disease. J Dev Orig Health Dis 2010;1:6-18.
3. Savilahti E, Kuitunen M, Vaarala O. Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol 2008;3:243-8.
4. Rowe J, Kusel M, Holt BJ, Suriyaarachchi D, Serralha M, Hollams E, et al. Prenatal versus postnatal sensitization to environmental allergens in a high-risk birth
cohort. J Allergy Clin Immunol 2007;119:1164-73.
5. Jones CA, Holloway JA, Warner JO. Does atopic disease start in foetal life? Allergy 2000;55:2-10.
6. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development
of allergen-specific T-cell memory in atopic and normal children. Lancet 1999;
353:196-200.
7. Macaubas C, Prescott SL, Venaille TJ, Holt BJ, Smallacombe TB, Sly PD, et al.
Primary sensitization to inhalant allergens. Pediatr Allergy Immunol 2000;11
(suppl 13):9-11.
8. Lucas A, Brooke OG, Cole TJ, Morley R, Bamford MF. Food and drug reactions,
wheezing, and eczema in preterm infants. Arch Dis Child 1990;65:411-5.
9. Kuehr J, Frischer T, Karmaus W, Meinert R, Barth R, Herrmann-Kunz E, et al.
Early childhood risk factors for sensitization at school age. J Allergy Clin Immunol
1992;90:358-63.
10. Arshad SH, Stevens M, Hide DW. The effect of genetic and environmental factors
on the prevalence of allergic disorders at the age of two years. Clin Exp Allergy
1993;23:504-11.
11. Stazi MA, Sampogna F, Montagano G, Grandolfo ME, Couilliot MF, Annesi-Maesano I. Early life factors related to clinical manifestations of atopic disease but not
to skin-prick test positivity in young children. Pediatr Allergy Immunol 2002;13:
105-12.
12. Katz KA, Pocock SJ, Strachan DP. Neonatal head circumference, neonatal weight,
and risk of hayfever, asthma and eczema in a large cohort of adolescents from
Sheffield, England. Clin Exp Allergy 2003;33:737-45.
13. David TJ, Ewing CI. Atopic eczema and preterm birth. Arch Dis Child 1988;63:
435-6.
14. Olesen AB, Ellingsen AR, Olesen H, Juul S, Thestrup-Pedersen K. Atopic dermatitis
and birth factors: Historical follow up by record linkage. BMJ 1997;314:1003-8.
15. Br
aback L, Hedberg A. Perinatal risk factors for atopic disease in conscripts. Clin
Exp Allergy 1998;28:936-42.
16. Siltanen M, Kajosaari M, Pohjavuori M, Savilahti E. Prematurity at birth reduces
the long-term risk of atopy. J Allergy Clin Immunol 2001;107:229-34.
17. Rasanen M, Kaprio J, Laitinen T, Winter T, Koskenvuo M, Laitinen LA. Perinatal
risk factors for hay fevera study among 2550 Finnish twin families. Twin Res
2001;4:392-9.
18. Siltanen M. Prematurity and atopy [doctoral dissertation]. Yliopistopaino,
Helsinki: University of Helsinki; 2004. Available at: http://ethesis.helsinki.fi/.
Accessed January 26, 2011.
19. Sears MR, Holdaway MD, Flannery EM, Herbison GP, Silva PA. Parental and neonatal risk factors for atopy, airway hyper-responsiveness, and asthma. Arch Dis
Child 1996;75:392-8.
20. Butland BK, Strachan DP, Lewis S, Bynner J, Butler N, Britton J. Investigation into
the increase in hay fever and eczema at age 16 observed between the 1958 and
1970 British birth cohorts. BMJ 1997;315:717-21.
21. Steffensen FH, Srensen HT, Gillman MW, Rothman KJ, Sabroe S, Fischer P, et al.
Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology 2000;11:185-8.
22. Mai XM, Gaddlin PO, Nilsson L, Finnstrom O, Bjorksten B, Jenmalm MC, et al.
Asthma, lung function and allergy in 12-year-old children with very low birth
weight: a prospective study. Pediatr Allergy Immunol 2003;14:184-92.
23. Laerum BN, Svanes C, Gulsvik A, Iversen M, Thorarinsdottir HR, Gislason T,
et al. Is birth weight related to lung function and asthma symptoms in NordicBaltic adults? Respir Med 2004;98:611-8.
24. Laerum BN, Svanes C, Wentzel-Larsen T, Gulsvik A, Iversen M, Gislason T, et al.
The association between birth size and atopy in young North-European adults. Clin
Exp Allergy 2005;35:1022-7.
25. Liem JJ, Kozyrskyj AL, Huq SI, Becker AB. The risk of developing food allergy in
premature or low-birth-weight children. J Allergy Clin Immunol 2007;119:1203-9.
26. Mallen CD, Mottram S, Wynne-Jones G, Thomas E. Birth-related exposures and
asthma and allergy in adulthood: a population-based cross-sectional study of young
adults in North Staffordshire. J Asthma 2008;45:309-12.
27. Fergusson DM, Crane J, Beasley R, Horwood LJ. Perinatal factors and atopic disease in childhood. Clin Exp Allergy 1997;27:1394-401.
28. Pihkala J, Hakala T, Voutilainen P, Raivio K. Characteristic of recent fetal growth
curves in Finland. Duodecim 1989;105:1540-6.
29. Hovi P, Andersson S, Eriksson JG, Jarvenpaa AL, Strang-Karlsson S, Makitie O,
et al. Glucose regulation in young adults with very low birth weight. N Engl J
Med 2007;356:2053-63.
942 SILTANEN ET AL
46. Xu B, Pekkanen J, Hartikainen AL, Jarvelin MR. Caesarean section and risk of
asthma and allergy in adulthood. J Allergy Clin Immunol 2001;107:732-3.
47. Eggesb M, Botten G, Stigum H, Nafstad P, Magnus P. Is delivery by cesarean section a risk factor for food allergy? J Allergy Clin Immunol 2003;112:420-6.
48. Salam MT, Margolis HG, McConnell R, McGregor JA, Avol EL, Gilliland FD.
Mode of delivery is associated with asthma and allergy occurrences in children.
Ann Epidemiol 2006;16:341-6.
49. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the
intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:
516-20.
50. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-45.
51. Marra F, Marra CA, Richardson K, Lynd LD, Kozyrskyj A, Patrick DM, et al. Antibiotic use in children is associated with increased risk of asthma. Pediatrics 2009;
123:1003-10.
52. Kwinta P, Sawiec P, Klimek M, Lis G, Cichocka-Jarosz E, Pietrzyk JJ. Correlation
between early neonatal diet and atopic symptoms up to 5-7 years of age in very low
birth weight infants: follow-up of randomized, double-blind study. Pediatr Allergy
Immunol 2009;20:458-66.
53. Keski-Nisula L, Heinonen S, Remes S, Pekkanen J. Pre-eclampsia, placental
abruption and increased risk of atopic sensitization in male adolescent offspring.
Am J Reprod Immunol 2009;62:293-300.
54. Wright RJ. Prenatal maternal stress and early caregiving experiences: implications
for childhood asthma risk. Paediatr Perinat Epidemiol 2007;21(suppl 3):8-14.
55. Buske-Kirschbaum A, Fischbach S, Rauh W, Hanker J, Hellhammer D. Increased
responsiveness of the hypothalamus-pituitary-adrenal (HPA) axis to stress in newborns with atopic disposition. Psychoneuroendocrinology 2004;29:705-11.
56. Paavonen EJ, Strang-Karlsson S, Raikkonen K, Heinonen K, Pesonen AK, Hovi P,
et al. Very low birth weight increases risk for sleep-disordered breathing in young
adulthood: The Helsinki study of very low birth weight adults. Pediatrics 2007;120:
778-84.
57. Hovi P, Andersson S, Jarvenpaa AL, Eriksson JG, Strang-Karlsson S, Kajantie E,
et al. Decreased bone mineral density in adults born with very low birth weight: a
cohort study. PLoS Med 2009;6:e1000135.
58. Hovi P, Andersson S, Raikkonen K, Strang-Karlsson S, Jarvenpaa AL, Eriksson JG,
et al. Ambulatory blood pressure in young adults with very low birth weight.
J Pediatr 2010;156:54-9, e1.
59. Hack M. Adult outcomes of preterm children. J Dev Behav Pediatr 2009;30:460-70.
60. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from
infancy to adulthood. Lancet 2008;371:261-9.
Reproduced with permission of the copyright owner. Further reproduction prohibited without
permission.